EURO HEALTH Podcast

Health Podcast
  • 0.0 (0)
  • HEALTH & FITNESS
  • UPDATED MONTHLY
EURO HEALTH Podcast

The guests of this podcast are carefully selected professors, doctors and others, so as they are experts in the health sector and discuss a range of complex topics which should be debated by the European politicians in Brussels. The world is swelled by crises in the health sector but just a few get properly elaborated on. The EURO HEALTH Podcast is here to change the narrative and provide valuable perspectives on issues which might seem obsolete but are equally important as others. Moderated by Jan Klusáček.

  1. Ernest Groman: Smoke-free generation by 2040: Is the EU on the right track?

    APR 29

    Ernest Groman: Smoke-free generation by 2040: Is the EU on the right track?

    In this episode, host Jiři Svoboda is pleased to welcome Dr. Ernest Groman for the second time in the EuroHealth Podcast to discuss the progresses made in tackling tobacco addiction. We discuss different approach to regulation, taxation, and strategies to reduce the harm caused by smoking. Giving a critical assessment of the policymakers’ approach to restriction, Dr. Groman provides insights into how emerging products, such as e-cigarettes, can play a role in reducing smoking prevalence… if regulated right!   🗣SPEAKER Dr. Ernest Groman serves as a professor at the Medical Faculty of the University of Vienna and as the scientific director of the Vienna Nicotine Institute, where he leads efforts to study and mitigate the health impacts of nicotine and tobacco use. Since 2002, he has been involved in the development and implementation of smoking cessation programs in Lower Austria.   Doc. Groman also worked as a Scientific Advisor to the Austrian government, the Austrian Pharmaceutical Chamber, and the Austrian smoking cessation hotline. He represented Austria as a delegate to the WHO in the context of the negotiations on the Global Framework Convention on Tobacco Control.   Known for his pragmatic and evidence-based approach, he advocates for informed health policies, drawing from his deep understanding of addiction and public health dynamics in Austria and the broader European Union.   👀 FOLLOW US   Spotify: https://open.spotify.com/show/27oZmDwhNxNdWWW0IvqnVm?si=8e87042ce82d4a56 Apple Podcast: https://podcasts.apple.com/us/podcast/euro-health-podcast/id1573732306 X: https://x.com/EuroHealthP

    37 min
  2. Péter Kéri: Patients at the centre of mental health care

    FEB 20

    Péter Kéri: Patients at the centre of mental health care

    Struggling with illnesses put patients on a long, and sometimes hard, path to healing. Struggling with mental illnesses, which are often invisible and burdened with stigma, brings unexpected obstacles on patients’ journeys and experiences. How can their involvement in care help their recovery? We asked Peter Keri, president of GAMIAN-Europe, a prominent voice for patients struggling with their mental health in Europe.   People struggling with mental illnesses are significantly burdened in their healing by circumstances that surround and affect them, leading them to more struggles and hampering their full recovery. Listening to them and involving them in decisions over their care is crucial to remove these barriers and obstacles – stigma being the most important of them, leading to self-doubt, social exclusion, lack of access to care, and slowing the recovery process.   Although the Covid-19 pandemic was wrongly defined as a “mental health pandemic” – mental health struggles aren’t communicable diseases, after all – the increased discourse about the effects on mental health of lockdowns and living through difficult times helped normalized conversations around mental health. Raising awareness, however, is not enough: to improve the conditions of patients who struggle with mental ill-health, policymakers need to enact concrete policies.   What does the experience of a person affected with mental health conditions look like nowadays? Are patients listened to, both in healthcare and by policymakers? How does stigma, an all-encompassing, multi-faceted issue, affect the recovery journey of patients? How can advocates go beyond awareness raising to enact a true change? Peter Keri will get rid of all of your doubts in this episode of the Europe Health Podcast.   🗣SPEAKER   Péter Kéri is the President of GAMIAN-Europe, a pan-European organisation, representing the interests of persons affected by mental illness.   Mr Kéri worked for several years in advanced travel management, which led to a decade-long career organizing specialized group travel for multinational companies. His life changed when, at 43 years of age, he was diagnosed with schizophrenia: this experience led him on a healing journey where he understood the importance of raising awareness on the experiences of patients struggling with their mental health. 👀 FOLLOW US   Spotify: https://open.spotify.com/show/27oZmDw... Apple Podcast: https://podcasts.apple.com/us/podcast... X: https://x.com/EuroHealthP

    38 min
  3. Euro Health Podcast 2024 Special Episode

    12/31/2024

    Euro Health Podcast 2024 Special Episode

    It’s a wrap! 2024 came to an end, and it’s been quite a year for European health policies. From the shift in focus to cardiovascular diseases to innovative approaches in the treatment of addictions, from holistic approaches in the treatment of mental health disorders to improving the conditions of patients through advocacy, the Euro Health Podcast was there to cover the developments in the European health policy landscape for you.  We had the pleasure to welcome distinguished guests - policymakers, patients advocates, experts, and brilliant scientists, to bring you a variety of voices and perspectives on the present and future of healthcare in Europe. Enjoy this interesting wrap up of our 2024 episodes, but remember that season 3 is not done yet - keep following us in 2025, new episodes await! In the meantime, re-listen to season 3 on YouTube, Spotify and Apple Podcasts:  E1 - Viktor Mravčík: Restrictive approach to drugs is driven by ideology | YouTube | Spotify | Apple Podcasts E2 - Philippe Roux: Europe on the path to beating cancer | YouTube | Spotify | Apple Podcasts  E3 - Dimitrios Athanasiou: Legislation on new medicines is not brave enough | YouTube | Spotify | Apple Podcasts  E4 - Judit Bidló: Hungary’s agenda for EU health | YouTube | Spotify | Apple Podcasts E5 - Jane Mounteney: EUDA, Europe's new drug watchdog | YouTube | Spotify | Apple Podcasts  E6 - Gabriele Fischer: Ending the stigma on substance use disorders (SUD) | YouTube | Spotify | Apple Podcasts  Follow us on X: https://x.com/EuroHealthP

    12 min
  4. Gabriele Fischer: Ending the stigma on substance use disorders (SUD)

    11/13/2024

    Gabriele Fischer: Ending the stigma on substance use disorders (SUD)

    Did you know that addictions are mental health disorders? Despite the link not being obvious at first glance, it is clear for scientists and medical professionals: people suffering from substance use disorders should be treated first and foremost as psychiatric patients. Patients, however, still suffer from stigma from the general population, especially when it comes to people who consume drugs, and from being a low priority on the policymakers’ agenda. We discussed it with Dr. Gabriele Fischer, one of the leading European experts on substance use disorders and their treatment.   Addictions can touch many aspects of people’s lives – it’s not only about illicit substances, but also addictions coming from licit substances, such as eating disorders and gaming addictions. These should not be underestimated and come not only with their costs for public health budgets, but also with their burden on society in general.    How are mental health disorders and addictions connected? Who are the population groups most vulnerable to developing substance use disorders, and what are the best prevention options? What are the most effective treatments? Are there differences between addictions to licit and illicit substances? What are policymakers doing about this, and what can be done to raise awareness on evidence-based solutions? Dr. Fischer will reply to these and other questions in this episode of the Euro Health Podcast!   🗣SPEAKER   Dr. Fischer is the Medical Director of the Addiction Clinic at the Medical University of Vienna’s Department of Psychiatry and Psychotherapy.    Her work focuses on mental health and addiction, and she is specialized in both substance-related and behavioral addictions. With a career in addiction treatment beginning in 1994, she brings extensive experience treating addiction and associated mental health issues, while also contributing to advancing research in this field.   Dr. Fischer is deeply involved in medical education and has published extensively on addiction. She has led multiple research projects, and has played a key role in developing treatment strategies for addiction disorders. Her international collaborations include work with the World Health Organization, the UNODC, and the Austrian Supreme Health Council, and she is a member of the Scientific Board of the European Union Drugs Agency. 🎙 EURO HEALTH PODCAST Euro Health Podcast focuses on European health policy by giving voice to leading experts. The goal is to bring complex and evidence-based information, which could lead to a better Europe. Podcast is hosted by Jiří Svoboda. 👀 FOLLOW US   Spotify: https://open.spotify.com/show/27oZmDwhNxNdWWW0IvqnVm?si=8e87042ce82d4a56 Apple Podcast: https://podcasts.apple.com/us/podcast/euro-health-podcast/id1573732306 X: https://x.com/EuroHealthP

    30 min
  5. Jane Mounteney: EUDA, Europe's new drug watchdog

    10/16/2024

    Jane Mounteney: EUDA, Europe's new drug watchdog

    One of the world’s leading scientific hubs in the field of drugs and addiction is the European Monitoring Center for Drugs and Drugs Addictions (EMCDDA), which this summer acquired a new mandate and name, becoming the European Union Drugs Agency (EUDA). We asked Dr. Jane Mounteney, Head of the Public Health Union of the Agency, to guide us through this change.   The EMCDDA was born in the 1990s to face a health emergency in Europe, the heroine and HIV epidemics. Thanks to its incessant and high-quality scientific work, it became an internationally recognised authority in the field of drugs and addictions, and significantly impacted the sector’s landscape in the continent, also thanks to the introduction of approaches like harm reduction.   With respect to its predecessor, the EUDA acquired new responsibilities and a new mandate, such as a new focus on polydrug use and new tools for international and cross-border cooperation, while keeping collaborating with policymakers and civil society.   What are the reasons why the EMCDDA evolved into the EUDA? What changed in the drugs and drug addiction landscape in Europe in the last decades? What is the impact of the scientific and evidence-based approaches developed by the Agency, such as the harm reduction approach? How does the Agency intend to address new challenges, such as the combined consumption of licit and illicit drugs? Let Dr. Mounteney introduce you through this season of change in this episode of the Euro Health Podcast!   🗣SPEAKER   Dr. Jane Mounteney is the Head of the Public Health Union at the European Union Drugs Agency (EUDA).    She has been involved in drug research, policy, and practice since 1994. In 2010, Dr. Mounteney joined the EMCDDA, renamed EUDA following a revision of its mandate. In her role, she oversees key areas including epidemiology, policy, and practice related to drug use and its impact.   Throughout her career at the EUDA, Dr. Mounteney has been the lead writer on the European Drug Report and has published numerous scientific articles. Her work in this area has led to the establishment of various European and city-level systems and projects aimed at addressing these emerging challenges.  🎙 EURO HEALTH PODCAST Euro Health Podcast focuses on European health policy by giving voice to leading experts. The goal is to bring complex and evidence-based information, which could lead to a better Europe. Podcast is hosted by Jiří Svoboda. 👀 FOLLOW US   Spotify: https://open.spotify.com/show/27oZmDwhNxNdWWW0IvqnVm?si=8e87042ce82d4a56 Apple Podcast: https://podcasts.apple.com/us/podcast/euro-health-podcast/id1573732306 X: https://x.com/EuroHealthP

    34 min
  6. Judit Bidló: Hungary’s agenda for EU health

    09/20/2024

    Judit Bidló: Hungary’s agenda for EU health

    The Hungarian Presidency of the Council of the EU (HUPRES) is steering the European Union boat to face present and future challenges for the health of Europeans. We had the chance to discuss them in a conversation with Dr. Judit Bidló, Hungarian Deputy State Secretary for the Professional Management of Health at the Ministry of the Interior, to dive deep into the HUPRES health agenda.   Every six months, one of the EU Member States takes control of the Presidency of the Council of the EU, one of the legislative bodies of the European Union. From July to December, it is Hugary’s turn to hold this prestigious position, which allows it to set the priorities for its six-month term and guide discussions on legislative and policy issues. Dr. Judit Bidló helps us understand the rationale behind Hungary’s top priority choices in health and their impact on the European and national context.   HUPRES decided to put under the spotlight two key topics: cardiovascular diseases and organ donation and transplantation. Cardiovascular diseases, responsible for almost one third of all deaths in the EU, are “Europe’s No. 1 killer”, and a well-known health emergency with insufficient harmonisation in prevention policies. The organ transplantation landscape is highly fragmented in Europe, with good-performing countries and others suffering organ shortages.    Why were these topics chosen, and what is the impact of this choice in the EU health agenda and in the reshuffling of health political priorities? What type of policy recommendations can we expect from HUPRES? How does HUPRES intend to act on drafting a prevention plan for cardiovascular diseases, especially when it comes to promoting healthy lifestyles and limiting tobacco and alcohol consumption? How is HUPRES continuing the work on mental health initiated by the preceding presidencies? Listen to Dr. Bidló discuss these and other topics in this episode of the Euro Health Podcast!   🗣SPEAKER   Dr. Judit Bidló is the Deputy State Secretary for the Professional Management of Health at Hungary’s Ministry of the Interior.    With an academic background in pharmacy, economics, and biomedical and medical engineering, she started working at the Hungarian National Health Insurance Fund in 2009, focusing on pricing, reimbursement of medicines, and health services. By 2018, she was appointed Deputy General Director, where her responsibilities included managing the availability of drugs and medical devices for patients and overseeing the funding and reimbursement processes.   In March 2023, Dr. Bidló took on the role of Deputy State Secretary for the Professional Management of Health at Hungary’s Ministry of the Interior, which contributed to draft the health priorities of the Hungarian Presidency of the Council of the EU (HUPRES). 🎙 EURO HEALTH PODCAST  Euro Health Podcast focuses on European health policy by giving voice to leading experts. The goal is to bring complex and evidence-based information, which could lead to a better Europe. Podcast is hosted by Jiří Svoboda. 👀 FOLLOW US    Spotify: https://open.spotify.com/show/27oZmDwhNxNdWWW0IvqnVm?si=8e87042ce82d4a56 Apple Podcast: https://podcasts.apple.com/us/podcast/euro-health-podcast/id1573732306 X: https://x.com/EuroHealthP

    32 min
  7. Dimitrios Athanasiou: Rare diseases, not as rare as you think

    08/22/2024

    Dimitrios Athanasiou: Rare diseases, not as rare as you think

    How rare are rare diseases? We asked Dimitrios Athanasiou, a prominent rare diseases patient advocate, president of Rare Diseases Greece and founder of 95 Rare Alliance Greece, and member of the Patients and Consumers Working Party in the European Medicines Agency. In this episode, Mr. Athanasiou reveals that what we think we know about rare diseases is just the tip of the iceberg. Not only do rare diseases affect a far larger number of people than we might imagine, but there is also much more complexity behind their diagnosis and treatment. Accessibility to care, diagnosis and treatment are hindered by high barriers, and patients and their families may risk further discrimination and isolation. Engaging with policymakers is another crucial aspect to create impact and change for rare diseases patients. Both in member states and in the European Union, patients advocates draw the attentions of decision makers on this important public healthcare issue. The European Medicines Agency is tasked with the approval of new drugs, but the process is often slow and the progress is not brave enough. How many people are actually affected by rare diseases? What are the visible and invisible barriers that prevent rare disease patients from accessing diagnosis and treatment? In which way children are disproportionately affected? What are European lawmakers doing on this issue? How to design a brave and impactful legislation to address rare diseases? How could the reform of the European Medicines Agency affect progress in this area? Learn more about rare diseases in this episode of the Europe Health Podcast!  🗣SPEAKER  Mr. Athanasiou’s engagement into rare disease advocacy began after his son was diagnosed with Duchenne Muscular Dystrophy, a rare and incurable condition. After a period of training, he started his advocacy activity in in Greece, but quickly expanded to the European level. Mr. Athanasiou holds leadership positions in several rare disease organizations. He is a founding member of 95 Rare Alliance Greece, the greek patients association, and is the chair of Rare Diseases Greece. He is also a representative for the Muscular Dystrophy Association HELLAS, and a board member of both the World Duchenne Organization (WDO) and the European Patient Forum (EPF)  In 2014, he was appointed as a patient expert for Duchenne Muscular Dystrophy by the European Medicines Agency. He served on the EMA’s Paediatric Committee until 2023 and now participates in the Patients’ and Consumers’ Working Party. His advocacy work involves close collaboration with regulators, health authorities, industry, and academia to ensure that patients with rare diseases have access to high-quality care and innovative treatments. 🎙 EURO HEALTH PODCAST  Euro Health Podcast focuses on European health policy by giving voice to leading experts. Our goal is to contribute to the debate on better healthcare in Europe, from a policy and a scientific perspective. The podcast is hosted by Jiří Svoboda.  👀 FOLLOW US Spotify: https://open.spotify.com/show/27oZmDwhNxNdWWW0IvqnVm?si=8e87042ce82d4a56 Apple Podcast: https://podcasts.apple.com/us/podcast/euro-health-podcast/id1573732306 X: https://x.com/EuroHealth

    38 min
  8. Philippe Roux: Europe on the path to beating cancer

    07/04/2024

    Philippe Roux: Europe on the path to beating cancer

    For this episode of the Euro Health Podcast, we had the honour of welcoming Philippe Roux, Acting Director for ‘Public Health, Cancer and Health Security’ Unit, and Head of Unit for ‘Cancer, Health in all Policies’ at the European Commission Directorate-General for Health and Food Safety (DG SANTE), to have a conversation around the EU’s response to cancer. In the past five years, the fight against cancer has been highly prioritised by the European institutions: both the European Commission and the European Parliament published ambitious initiatives for prevention and treatment. Philippe Roux is in charge of coordinating actions to tackle cancer in the European Commission, including the comprehensive Europe Beating Cancer Plan (EBCP), one of the key initiatives of the Commission in the area of health. One objective: fighting a disease that affects millions of Europeans through the promotion of healthy lifestyles, innovations in treatment, and improved accessibility to diagnosis and quality care. We asked Philippe Roux to walk us through some of the most important initiatives contained in the Plan, from the improvement of health literacy to the reduction of risky behaviours. What were the biggest achievements reached so far? How are the European institutions working together towards this common goal, and what is the role of the Member States? How is the Commission responding to the suggestions and requests of citizens, collected during the public consultations? Listen to the episode to learn it and much more! 🗣SPEAKER Our guest for today, Philippe Roux, is a civil servant with decades-long experience in health policy. He started his career in the French social sector in the 80s, after which he worked in the European Commission in support of the development of the EU initiatives related to drug prevention. He later joined the European Monitoring Centre for Drugs and Drug Addictions (EMCDDA), where he contributed to the development of the framework and tools for the evaluation of the EU action plans on drugs. His experience in the Directorate-General for Health (DG SANTE) in the European Commission started the Nutrition and Physical Activity team of on the coordination of the European Platform on Diet, Physical Activity and Health. He became Head of Unit for ‘Cancer, Health in all Policies’ shortly after the publication of the Europe’s Beating Cancer Plan, in 2022, with the responsibility to implement policies and organise activities to achieve the objectives of the Plan. He later became Acting Director for ‘Public Health, Cancer and Health Security’. 🎙 EURO HEALTH PODCAST Euro Health Podcast focuses on European health policy by giving voice to leading experts. Our goal is to contribute to the debate on better healthcare in Europe, from a policy and a scientific perspective. The podcast is hosted by Jiří Svoboda. 👀 FOLLOW US  Spotify: https://open.spotify.com/show/27oZmDwhNxNdWWW0IvqnVm?si=8e87042ce82d4a56 Apple Podcast: https://podcasts.apple.com/us/podcast/euro-health-podcast/id1573732306 X: https://x.com/EuroHealth

    24 min
See All (31)

About

The guests of this podcast are carefully selected professors, doctors and others, so as they are experts in the health sector and discuss a range of complex topics which should be debated by the European politicians in Brussels. The world is swelled by crises in the health sector but just a few get properly elaborated on. The EURO HEALTH Podcast is here to change the narrative and provide valuable perspectives on issues which might seem obsolete but are equally important as others. Moderated by Jan Klusáček.

Information

  • Creator
    Health Podcast
  • Years Active
    2021 - 2025
  • Episodes
    31
  • Rating
    Explicit
  • Copyright
    © 2025 EURO HEALTH Podcast
  • Show Website
    EURO HEALTH Podcast

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes, and get the latest updates.
Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada